Federal Register of Legislation - Australian Government

Primary content

PB 5 of 2014 Determinations/Health as made
This instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (No. PB 79 of 2011) to remove one listed brand for the listed drug ‘Paclitaxel’.
Administered by: Health
Registered 23 Jan 2014
Tabling HistoryDate
Tabled HR11-Feb-2014
Tabled Senate11-Feb-2014
Date of repeal 02 Feb 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 5 of 2014

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2014 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, Kim Bessell, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

 

Dated  17 January 2014

 

 

 

 

 

 

 

 

 

 

 

KIM BESSELL

Assistant Secretary

Pharmaceutical Access Branch

Principal Pharmacy Advisor

Pharmaceutical Benefits Division

Department of Health

 

___________________________________________________________________

 

 

1              Name of Instrument

 

(1)                This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2014 (No.1).

 

(2)                This Instrument may also be cited as PB 5 of 2014.

 

2             Commencement

                This Instrument commences on 1 February 2014.

3              Amendments to PB 79 of 2011

                      Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

 

 


Schedule 1                   Amendments

 

[1]    Schedule 1 Part 1, entry for Paclitaxel in the form Solution concentrate for I.V. infusion 300 mg in 50 mL with manner of administration Injection:

omit:

                                                                                                                 

Paclitaxel Pfizer

 

PF

MP

C3186

C3890 

C3902

C3917

C3955

C3956

D